Chemical Formula: C37H69O7P

Chemical Formula C37H69O7P

Found 28 metabolite its formula value is C37H69O7P

PA(P-16:0/18:2(9Z,12Z))

[(2R)-3-[(1Z)-hexadec-1-en-1-yloxy]-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy]phosphonic acid

C37H69O7P (656.4780653999999)


2-(9Z,12Z-octadecadienoyl)-1-(1Z-hexadecenyl)-sn-glycero-3-phosphate is an intermediate of ether lipid metabolism. Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. 2-(9Z,12Z-octadecadienoyl)-1-(1Z-hexadecenyl)-sn-glycero-3-phosphate is irreversibly produced from 2-(9Z,12Z-octadecadienoyl)-1-(1Z-hexadecenyl))-sn-glycero-3-phosphoethanolamine via the enzyme phospholipase D (EC: 3.1.4.4). Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. 2-(9Z,12Z-octadecadienoyl)-1-(1Z-hexadecenyl)-sn-glycero-3-phosphate is an intermediate of ether lipid metabolism. Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage.

   

PA(P-16:0e/18:2(9Z,12Z))

2-(9Z,12Z-Octadecadienoyl)-1-(1Z-hexadecenyl)-sn-glycero-3-phosphate

C37H69O7P (656.4780653999999)


   

PA(O-16:0/18:3(9Z,12Z,15Z))

1-hexadecyl-2-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphate

C37H69O7P (656.4780653999999)


   

PA(O-16:0/18:3(6Z,9Z,12Z))

1-hexadecyl-2-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phosphate

C37H69O7P (656.4780653999999)


   

PA(P-16:0/18:2(9Z,12Z))

1-(1Z-hexadecenyl)-2-(9Z,12Z-octadecadienoyl)-glycero-3-phosphate

C37H69O7P (656.4780653999999)


   

PA O-34:3

1-(1Z-hexadecenyl)-2-(9Z,12Z-octadecadienoyl)-glycero-3-phosphate

C37H69O7P (656.4780653999999)


   

BisMePA(32:3)

BisMePA(16:2(1)_16:1)

C37H69O7P (656.4780653999999)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   
   
   

PA P-14:0/20:2 or PA O-14:1/20:2

PA P-14:0/20:2 or PA O-14:1/20:2

C37H69O7P (656.4780653999999)


   
   

PA P-16:0/18:2 or PA O-16:1/18:2

PA P-16:0/18:2 or PA O-16:1/18:2

C37H69O7P (656.4780653999999)


   
   

PA P-16:1/18:1 or PA O-16:2/18:1

PA P-16:1/18:1 or PA O-16:2/18:1

C37H69O7P (656.4780653999999)


   
   

PA P-18:1/16:1 or PA O-18:2/16:1

PA P-18:1/16:1 or PA O-18:2/16:1

C37H69O7P (656.4780653999999)


   
   

PA P-20:1/14:1 or PA O-20:2/14:1

PA P-20:1/14:1 or PA O-20:2/14:1

C37H69O7P (656.4780653999999)